BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 35169839)

  • 1. Regulation of HTLV-1 transformation.
    Ernzen KJ; Panfil AR
    Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35169839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.
    Rushing AW; Hoang K; Polakowski N; Lemasson I
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ.
    Giam CZ; Semmes OJ
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27322308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.
    Yasuma K; Matsuzaki T; Yamano Y; Takashima H; Matsuoka M; Saito M
    J Neurovirol; 2016 Aug; 22(4):416-30. PubMed ID: 26635027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein.
    Accolla RS
    Front Immunol; 2022; 13():940131. PubMed ID: 35812456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
    Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
    Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the HTLV-1 viral factors in the induction of apoptosis.
    Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B
    Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
    Satou Y; Yasunaga J; Yoshida M; Matsuoka M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB.
    Zhao T; Yasunaga J; Satou Y; Nakao M; Takahashi M; Fujii M; Matsuoka M
    Blood; 2009 Mar; 113(12):2755-64. PubMed ID: 19064727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
    Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
    Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets.
    Marino-Merlo F; Grelli S; Mastino A; Lai M; Ferrari P; Nicolini A; Pistello M; Macchi B
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30
    Hutchison T; Malu A; Yapindi L; Bergeson R; Peck K; Romeo M; Harrod C; Pope J; Smitherman L; Gwinn W; Ratner L; Yates C; Harrod R
    Virology; 2018 Jul; 520():39-58. PubMed ID: 29777913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells.
    Usui T; Yanagihara K; Tsukasaki K; Murata K; Hasegawa H; Yamada Y; Kamihira S
    Retrovirology; 2008 Apr; 5():34. PubMed ID: 18426605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of HBZ in HTLV-1-Induced Oncogenesis.
    Zhao T
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26848677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.
    Panfil AR; Dissinger NJ; Howard CM; Murphy BM; Landes K; Fernandez SA; Green PL
    J Virol; 2016 Jan; 90(7):3760-72. PubMed ID: 26819304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses.
    Naito T; Ushirogawa H; Fukushima T; Tanaka Y; Saito M
    Virol J; 2019 Dec; 16(1):160. PubMed ID: 31856855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.